Carregant...
DNMT3A and TET2 in the Pre-Leukemic Phase of Hematopoietic Disorders
In recent years, advances in next-generation sequencing (NGS) technology have provided the opportunity to detect putative genetic drivers of disease, particularly cancers, with very high sensitivity. This knowledge has substantially improved our understanding of tumor pathogenesis. In hematological...
Guardat en:
| Publicat a: | Front Oncol |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Frontiers Media S.A.
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4992944/ https://ncbi.nlm.nih.gov/pubmed/27597933 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2016.00187 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|